Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy burps are a well-recognised side effect of semaglutide treatment: the medicine slows gastric emptying, which means food and gas linger in the stomach longer than usual, producing excess belching for some people. The good news is that burping tends to be worst in the first few weeks of treatment and usually settles on its own. What you eat and how you eat it can make a meaningful difference while your body adjusts. The broader picture of Wegovy's side-effect profile puts burping in context — it sits alongside nausea and indigestion rather than being a danger sign. These are prescription-only medicines, and a prescriber reviews every consultation; the practical guidance here supports, but does not replace, that clinical relationship.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
When burping is disrupting daily life, the instinct is often to wonder whether to stop treatment. That is rarely the right call. The more useful question is which of several overlapping factors (meal composition, eating pace, drink choices, or dose timing) is contributing most for you personally. Most people find one or two adjustments makes the burping tolerable, even if it doesn't vanish entirely.
Semaglutide extends the time your stomach takes to empty its contents, so gas that would normally move through quickly sits around longer. Fatty, rich meals amplify this; so do carbonated drinks, which add gas on top of the mechanical delay. Eating quickly, talking during meals and using straws all introduce extra air. None of these things is specific to Wegovy (they aggravate belching in anyone) but they land harder when gastric emptying is already slowed.
The side-effect timeline for Wegovy is worth understanding here: burping, like nausea, typically peaks in the first two to four weeks at a new dose and then softens. If you are freshly started or have just moved up a step, some patience alongside the dietary changes below is often the most realistic approach. That said, if burping is severe or accompanied by reflux severe enough to disrupt sleep or work, mention it to your prescriber before the next scheduled review.
Smaller, more frequent meals are the most consistently helpful adjustment. A large meal demands more gastric processing at once; a smaller one moves more easily. Aiming for three modest meals rather than two large ones is a practical place to start, and the reduced appetite that comes with semaglutide actually makes smaller portions feel natural for most people rather than like a sacrifice.
Eating pace matters more than most people expect. Sitting down, putting utensils down between bites and chewing thoroughly before swallowing reduces the air you ingest. It also gives your stomach signals it needs to regulate fullness properly, which can reduce the uncomfortable over-full feeling that often triggers belching after meals on Wegovy.
On the drink side, swapping sparkling water or fizzy drinks for still water is one of the simplest changes available. Coffee on an empty stomach can aggravate both nausea and reflux in the early weeks; tea or water first, then coffee after a small amount of food, tends to sit better. Alcohol and high-fat foods both slow gastric emptying further (already the mechanism at the root of the problem) so cutting back on both while you adjust is reasonable.
High-fibre foods are valuable for overall gut health, but very large portions of cruciferous vegetables (broccoli, cabbage, cauliflower) produce fermentation gas in the colon that adds to the overall burden. Moderate portions rather than avoidance is the practical note here. More detail on managing the full range of gut-related symptoms is available on the Wegovy side effects management page.
Wegovy is a once-weekly injection and the day you take it is flexible, provided it stays consistent. Some patients notice their GI symptoms are slightly more pronounced in the 24 to 48 hours after injecting, so if your injection day currently falls midweek and you are finding burping particularly disruptive at work, shifting it to, say, a Friday means the peak discomfort lands over a weekend. That kind of small logistical adjustment is easy to overlook but makes a real difference to how manageable treatment feels. If you are on a regular Wegovy schedule and wondering whether changing your injection day is fine to do, check with your prescriber first.
Propping yourself slightly upright for 20 to 30 minutes after meals (rather than lying down immediately) helps gravity assist gastric emptying and reduces reflux. It is a simple postural change that costs nothing. Over-the-counter antacids can ease reflux symptoms but are worth discussing with a pharmacist or your prescriber before making them a regular habit alongside semaglutide, since they can interact with how other medicines are absorbed.
For some people the issue goes beyond ordinary belching, a particularly strong sulphur or egg-like smell is occasionally reported. This is covered in detail on the page addressing sulphur burps on Wegovy, including why it happens and what tends to help. The NHS patient-level information for semaglutide, available on the NHS medicines page for semaglutide, also covers common gastrointestinal effects and when to contact a doctor.
Burping alone, even if annoying, is not a medical emergency. There are, however, symptoms that should prompt prompt attention rather than self-management. Severe stomach pain (especially pain that is persistent and radiates toward the back, with or without vomiting) is the key red flag. In January 2026 the MHRA issued a Drug Safety Update for GLP-1 medicines, specifically highlighting acute pancreatitis as a known serious but infrequent risk. That update reinforces the advice already in the Patient Information Leaflet: do not try to wait out severe abdominal pain. Call 111 or attend A&E if you are concerned.
Beyond that specific warning, contact your prescriber if burping or associated reflux and nausea is making it genuinely hard to eat, drink or sleep after two to three weeks at a dose. A prescriber can discuss whether a slower titration, a change in injection timing, or another practical step is appropriate, it is exactly the kind of question a good weight-loss service exists to help with. You can also report any suspected side effects via the MHRA's Yellow Card scheme, which helps regulators monitor real-world medicine safety.
If you are weighing up the overall cost picture of treatment alongside managing side effects like this, the Wegovy price comparison page sets out what a fully supported private prescription tends to include. And if you would like a prescriber to review your current symptoms or titration plan, the free consultation is the straightforward next step.
Speak to our prescribers, your consultation is reviewed the same day by a GPhC-registered clinician, not a chatbot.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.